Alerts
Other content recommended for you
- Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma
- Uveal melanoma-associated cancers revisited
- Methylation of CpG island promoters in uveal melanoma
- Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy
- Metastatic disease from uveal melanoma: treatment options and future prospects
- CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation
- The Zimmerman-McLean-Foster hypothesis: 25 years later
- The relation between c-myc expression and interferon sensitivity in uveal melanoma
- Chromosomal aberrations in iris melanomas
- Implications of LAG3 and CTLA4 immune checkpoints beyond PD-1/PD-L1 as a potential target in determining the prognosis of uveal melanoma patients